热门资讯> 正文
KRTL Holding将与Industria Químico Farmacéutica Sigma S.RL合并
2025-09-09 21:58
- KRTL Holding Group (OTCPK:KRTL) said on Tuesday that its wholly owned subsidiary, KRTL Biotech, has completed a merger by exchange of quotas and shares agreement with Industria Químico Farmacéutica Sigma, a leading Bolivian pharmaceutical manufacturer.
- Under the terms of the share and quotas exchange agreement executed on September 2, 2025, the Wilstermann Family, owners of 100% of SIGMA, shall transfer 99% of SIGMA’s capital quotas to KRTL Biotech.
- In exchange, KRTL Holding, through KRTL Biotech, will issue 490M common shares of KRTL Biotech, representing 49% of KRTL Biotech’s issued and outstanding shares, to the Wilstermann Family.
- Additionally, KRTL Holding will issue one preferred share to Patricia Wilstermann, granting her a permanent board seat on KRTL Holding’s board.
- This strategic transaction preserves SIGMA’s local operations, licenses, and management while granting KRTL Biotech a majority beneficial interest in SIGMA for financial consolidation.
- SIGMA’s results will now be consolidated into KRTL Biotech’s financial statements, which are, in turn, consolidated into KRTL Holding’s reporting.
More on KRTL Holding Group, Inc.
- Financial information for KRTL Holding Group, Inc.
推荐文章
风险及免责提示：以上内容仅代表作者的个人立场和观点，不代表华盛的任何立场，华盛亦无法证实上述内容的真实性、准确性和原创性。投资者在做出任何投资决定前，应结合自身情况，考虑投资产品的风险。必要时，请咨询专业投资顾问的意见。华盛不提供任何投资建议，对此亦不做任何承诺和保证。
